Warning: count(): Parameter must be an array or an object that implements Countable in C:\Servx\alembicpharmaceuticals.com\httpdocs\wp-includes\post-template.php on line 284
<< Back

Corazon is a youngest division of Alembic’s cardio-metabolic team. Journey of Corazon embarked in the year 2014 with two focused brands Rosave and Vogo. Within a couple of years, the team marked its presence in market by increasing prescribers and prescriptions. During this journey, brands have been strengthened by the team through successful launching of new extensions to Rosave and Vogo. Trivogo has become an upcoming blockbuster brand for the team. With a strong cardiac portfolio comprising a range of Rosuvastatin products, from plain Rosuvastatin to combinations with Fenofibrate (Rosave F), Clopidogrel (Rosave C) and Cholecalciferol (Rosave D) and recently launched triple combination of Rosuvastatin, Clopidogrel and Aspirin (RosaveTrio), Alembic Corazon is now making inroads to the chronic market. Apart from statin, Corazon also has a strong anti-diabetic portfolio with the Vogo Range, comprising of plain Voglibose (Vogo), also in combination with metformin (Vogo-M), and recently launched triple combination (TriVogo). To serve Diabetes specialist better, we have recently introduced Alnex NT for Diabetic Neuropathy patients. With presence of all these wide treatment options Corazon has become 7th division in its represented market. With having Zeal & passion within, we are expecting to touch more such milestones in future.

Megabrands / Focus brands – Rosave and TriVogo

Sr. No. Brand Molecule Indication
1. ROSAVE Micronized Rosuvastatin 5/10/20/40 Management of Dyslidemia
2. ROSAVE-F Rosuvastatin 5/10/20 + Micronized Fenofibrate 160 In mixed and diabetic dyslipidemia
3. ROSAVE-D Rosuvastatin 5/10/20 + Cholecalciferol 1000 I.U. In high cardiovascular risk patients with Vitamin D3 deficiency
4. ROSAVE-C Rosuvastatin 10/20 + Clopidogreal 75 In ACS
5. ROSAVE TRIO Rosuvastatin 10/20 + Clopidogreal 75 + Aspirin 75 In PCI
6. VOGO Voglibose 0.2/0.3 In T2DM
7. VOGO-M Voglibose 0.2/0.3 + Metformin 500 In Obese Diabetics
8. TRIVOGO 0.2/ 1 & 2 Voglibose 0.2 + Metformin 500 + Glimepiride 1/2 In T2DM for aggressive glycemic control
9. TRIVOGO 0.3/ 1 & 2 Voglibose 0.3 + Metformin 500 + Glimepiride 1/2 In T2DM for aggressive glycemic control
10. ALNEX-NT Pregabalin 75 + Nortriptyline 10 Diabetic Peripheral Neuropathy

corazon mega brands